David Nadel on The Street: "Four International Stocks With Room to Run"
article 04-22-2016

David Nadel on The Street: "Four International Stocks With Room to Run"

Portfolio Manager David Nadel joins The Street for a discussion on four stock picks in Royce International Premier Fund. 

TELL US
WHAT YOU
THINK

David_Nadel_TheStreet

By clicking the above link, you'll leave this site and go to a third-party website. Royce does not endorse and accepts no responsibility for content on third-party sites.

On April 19, 2016, Portfolio Manager David Nadel joined The Street for a discussion on four stock picks in Royce International Premier Fund.

David explains why he likes the four companies, including Spirax Sarco, a U.K.-based supplier of steam and pumping equipment. The company is the global leader in its industry.

VZ Holding, a Swiss wealth manager with a visibility revenue model that David likes with a large potential customer base.

David has visited India several times to visit companies, including the Indian company Bajaj Finance, which is a consumer lender and could potentially have a long runway of growth.

Last, David discusses Santen Pharma, a Japanese pharmaceutical company that specializes in eye and ophthalmic drugs.

You can watch the interview here.

Important Disclosure Information

David Nadel is Director of International Research and a Portfolio Manager of Royce & Associates, LP, investment adviser to The Royce Funds. He is the portfolio manager of Royce International Premier Fund (RIP. He also assists Royce Global Value Trust (RGT), and Royce Value Trust (RVT). The thoughts and opinions expressed in the video are solely those of the person speaking and may differ from those of other Royce investment professionals, or the firm as a whole. There can be no assurance with regard to future market movements.

This material is not authorized for distribution unless preceded or accompanied by a current prospectus. Please read the prospectus carefully before investing or sending money. Smaller-cap stocks may involve considerably more risk than larger-cap stocks. (Please see "Primary Risks for Fund Investors" in the prospectus.)

Percentage of Fund Holdings as of 3/31/16 (%)

  Spirax Sarco VZ Holding Santen Pharma Bajaj Finance
International Premier 2.34 2.41 1.92 2.67
Value Trust 0.00 0.00 0.00 0.00
Global Value Trust 1.63 1.40 1.65 1.23

There can be no assurance that any of the securities mentioned in the interview will be included in these portfolios in the future. References to specific securities in this interview are not intended as recommendations and should not be relied upon as the basis for anyone to buy, sell, or hold any security.

Share:

Subscribe:

Sign Up

Follow: